羟基喜树碱联合丝裂霉素诱导人白血病K562细胞凋亡

观察羟基喜树碱与丝裂霉索联合应用对人白血病细胞K562的作用效果,并探讨其机制。不同浓度羟基喜树碱与丝裂霉素单独及联合作用于人白血病细胞K562后,应用台盼蓝拒染法检测细胞生长抑制率,计算合用指数（CI）,流式细胞仪（FCM）检测K562细胞凋亡率,吖啶橙（AO）荧光染色和透射电镜观察凋亡形态学变化。结果表明：单独应用时羟基喜树碱和丝裂霉素的IC50分别是8μ/mL和12．5μg/mL,联合应用时IC50下降为4μg/mL（HCPT）和3．6μg/mL（MMC）,CI=0．78,为协同效应。羟基喜树碱与丝裂霉素单独及联合应用均可诱导K562细胞凋亡。2种药物联合应用时的凋亡率高于各自单独用药。羟基喜树碱与丝裂霉素联合应用可以通过共同诱导细胞凋亡。协同抑制人白血病细胞生长。     

槐果碱对人红白血病K562细胞的增殖抑制和诱导凋亡作用

研究了槐果碱对人红白血病细胞株K562的增殖抑制和诱导细胞凋亡的作用，应用流式细胞仪进一步观察槐果碱对K562细胞周期的影响。结果表明：槐果碱对K562细胞生长有明显的抑制作用，且这种抑制作用呈浓度依赖性、时间依赖性。细胞经0．8g／L、1．0g／L的槐果碱作用48h后，即呈现典型的细胞凋亡形态学变化，作用72h后DNA凝胶电泳出现片段的梯形条带。流式细胞仪分析显示，用1．0g／L槐果碱使K562细胞阻滞于G0／G1期，作用72h后G0／G1细胞比例由38．0％上升到56．2％。槐果碱对人红白血病细胞K562的增殖具有明显的抑制作用，并能诱导其发生凋亡。     

石蒜碱诱导人白血病K562细胞凋亡的研究

为研究石蒜碱诱导白血病K562细胞凋亡机制,采用体外细胞培养方式,通过CCK-8法描绘细胞生长曲线,测定细胞增殖活性,CCK-8结果显示石蒜碱能够抑制K562细胞生长,且呈现剂量依赖性,其IC50=4.13μmol/L.倒置显微镜进行细胞形态学观察,石蒜碱作用细胞后,细胞形态学发生改变.PI单染法检测细胞凋亡率,数据显示,石蒜碱诱导K562细胞的凋亡率与给药剂量呈正相关.Western-blot法检测P53蛋白表达情况,随着石蒜碱浓度的增加,P53活性增强(P0.05).结果显示,石蒜碱抑制白血病K562细胞增殖,诱导细胞凋亡,其凋亡诱导作用可能与细胞内P53基因的表达有关.     

辛伐他汀联合5-FU对K562细胞增殖及凋亡的影响

目的:探讨辛伐他汀(Sim)联合5-FU对白血病K562细胞增殖及凋亡的影响,探讨其作用机制。方法:体外培养人白血病K562细胞,用MTT法观察Sim联合5-FU对细胞的增殖抑制作用,实时荧光定量RT-PCR观察对bcr/abl融合基因mRNA表达水平的影响。流式细胞术、Hoechst33258染色观察Sim与5-FU联合应用诱导细胞凋亡的作用。结果:低浓度的Sim与5-FU联合应用在抑制细胞的增殖,诱导细胞凋亡,均较各单一高浓度用药组的作用明显增强,并且下调bcr/abl融合基因mRNA表达。结论:Sim与5-FU联用具有明显的协同抑制细胞增殖的作用,其作用机制可能与诱导细胞凋亡,下调bcr/abl融合基因的表达有关。     

土贝母苷甲诱导人红白血病细胞K562凋亡

用MTT法检测苷甲对K562细胞生长的抑制作用,分别采用形态学方法(光学显微镜、倒置显微镜、荧光显微镜)检查在苷甲作用下K562细胞形态的变化以及用流式细胞术观察在苷甲作用下K562细胞凋亡及周期变化的情况.结果显示:苷甲抑制K562细胞的生长,其24、48、72h的IC50值分别为19.7、18.5、15.9μmol/L.苷甲诱导K562细胞出现典型凋亡细胞的形态学特征.20μmol/L苷甲作用K562细胞6 h,流式细胞仪即检出亚倍体峰,G2/M期细胞增多.随着作用时间延长,细胞被阻滞于G2/M期更加明显,细胞的凋亡率也增加.该实验证明:苷甲能抑制K562细胞的生长,把细胞阻滞在G2/M期并诱导细胞发生凋亡.     

吲哚乙酸结合辣根过氧化物酶对K562细胞增殖的影响

应用MTT实验、细胞计数法检测吲哚乙酸结合辣根过氧化物酶,流式细胞仪(FCM)和DNA末端标记法(TUNEL)检测IAA/HRP对细胞增殖周期和细胞凋亡的作用,研究了吲哚乙酸(indole-3-acetic acid IAA)结合辣根过氧化物酶(horseradish peroxidase HRP)对K562细胞增殖的影响.结果表明,与对照组相比,IAA和HRP单独处理组对K562细胞的生长具有部分抑制作用,但无显著性差异;而IAA与HRP结合后对K562细胞的抑制作用明显增强.流式细胞仪检测结果表明,K562细胞阻滞于G2/M期.IAA/HRP具有明显的诱导K562细胞凋亡的作用,且诱导凋亡的作用与IAA浓度呈正相关(r=0.971,P<0.01).IAA/HRP能明显抑制K562细胞生长,将细胞周期阻滞于G2/M期,诱导细胞凋亡.     

石蒜碱对人白血病细胞K562凋亡作用的研究

为了研究石蒜碱对人白血病细胞K562的凋亡作用,采用MTT法检测石蒜碱对K562细胞的细胞毒作用,数据表明石蒜碱对K562细胞的IC50为16.000μmol/L.流式细胞仪检测石蒜碱对K562细胞凋亡率的影响,数据表明给药剂量越大,其凋亡率越高,凋亡率与给药剂量呈依赖关系.激光共聚焦扫描显微镜检测石蒜碱对K562细胞膜电位的影响,数据表明随着给药剂量增大,膜电位逐渐降低,且成剂量依赖关系.结果显示石蒜碱能够诱导K562细胞凋亡并使其膜电位降低.     

IL－10与放线菌酮诱导K562细胞凋亡

目的：研究IL－10对放线菌酮（CHX）诱导K562细菌凋亡所产生的调节作用。方法：采用碘化丙啶（PI）染色流式细胞仪分析，形态学观察及DNA凝胶电泳检测K562细胞。结果：CHX组K562凋亡细胞达58．3％，CHX加IL－10组达75．8％。结论：（1）CHX能诱导K562细胞凋亡。（2）IL－10和CHX联合作用诱导K562细胞凋亡的作用增强。     

Survivin基因在胃癌组织中的表达及其与凋亡的相关性研究

目的研究胃癌组织中Survivin基因的表达及其与凋亡的关系。方法应用免疫组织化学SP法检测30例正常胃粘膜及120例胃癌组织中Survivin基因的表达;采用脱氧核糖核酸末端转移酶介导的缺口末端标记（TUNEL）技术,检测其凋亡指数。结果30例正常胃粘膜组织Survivin基因均不表达,胃癌组织中Survivin阳性率为62．5％（75／120）,二者有显著性差异（P〈0．01）;Survivin基因表达与组织分化程度和TNM分期密切相关（P〈0．05）。胃癌组织凋亡指数（AI）和TNM分期、组织分化程度密切相关（P〈0．05）。Survivin基因表达水平与凋亡指数呈显著负相关（P〈0．01）。结论Survivin基因在胃癌的发生发展过程中可能起重要作用。Survivin基因的表达可抑制胃癌细胞凋亡、促进胃癌细胞增殖。     

血管内皮生长因子反义核酸增强HL60和K562细胞对As2O3的敏感性

目的：探讨血管内皮生长因子(VEGF)反义核酸能否提高HL60和K562细胞对三氧化二砷(As2O3)的敏感性。方法：采用经筛选所得的最优反义核酸(A7)，20个碱基经过全硫代修饰；以脂质体介导转染细胞，反义核酸和AsO3联合作用72h以后，用MTT法检测细胞生长情况，求IC50值；用ELISA法检测培养液中VEGF蛋白的浓度，用流式细胞仪检测细胞凋亡百分数。结果：VEGF反义核酸可显降低HL60、K562细胞对As2O3的IC50值，下调VEGF蛋白的表达，增加As2O3诱导的HL60、K562细胞凋亡作用。结论：VEGF反义核酸具有增强HL60和K562细胞对As2O3的敏感性，增强As2O3诱导的HL60和K562细胞凋亡作用；提示内源性VEGF蛋白具有使细胞产生耐药性的作用。     

微波和足叶乙苷体外诱导K562细胞凋亡的研究

探讨微波和足叶乙苷体外诱导Ｋ５６２细胞凋亡的可能性及其机制,将微波和足叶乙苷分别单独以及联合作用于下沉髓细胞和Ｋ５６２细胞株,通过细胞凋亡和ｂｃｌ－２蛋白阳性率的测试来评价细胞凋良的程度并研究其机制,微波和足叶乙苷各自都能诱导正常骨髓细胞和Ｋ５６２细胞的少量凋亡,两者联合作用所诱导的细胞凋亡率较之宇足叶乙苷有显著性增加,其中Ｋ５６２的细胞凋亡率的增加幅度远大于正常骨髓细胞,细胞凋亡率的增另和ｂｃｌ     

血管内皮生长因子反义核酸增强HL60和K562细胞对As_2O_3的敏感性

目的:探讨血管内皮生长因子(VEGF)反义核酸能否提高HL60和K562细胞对三氧化二砷(As2O3)的敏感性。方法:采用经筛选所得的最优反义核酸(A7),20个碱基经过全硫代修饰;以脂质体介导转染细胞,反义核酸和As2O3联合作用72h以后,用MTT法检测细胞生长情况,求IC50值;用ELISA法检测培养液中VEGF蛋白的浓度,用流式细胞仪检测细胞凋亡百分数。结果:VEGF反义核酸可显著降低HL60、K562细胞对As2O3的IC50值,下调VEGF蛋白的表达,增加As2O3诱导的HL60、K562细胞凋亡作用。结论:VEGF反义核酸具有增强HL60和K562细胞对As2O3的敏感性,增强As2O3诱导的HL60和K562细胞凋亡作用;提示内源性VEGF蛋白具有使细胞产生耐药性的作用。     

Apoptosis induced by （DIPP-L-Leu）2-L-Lys-OCH3 in K562 cells

Apoptosis as a mechanism of deleting cells from tissues plays an important role in physiological and varieties of pathological situations, especially cancer conditions. In order to search for tumor cells apoptosis inducers, the inhibition effects on K562 cells of N-phosphoryl dipeptide methyl esters were studied by MTT assays, and (DIPP-L-Leu)2-L-Lys-OCH3 was the compound which had the best activity. From the studies of the typical apoptotic morphologic changes, DNA agarose gel electrophoresis, and flow cytometry analysis, it could be concluded that (DIPP-L-Leu)2-L-Lys-OCH3 could induce apoptosis of K562 cells in a dose-dependent manner, and the IC50 was 22.66 μmol/L according to MTT assays.     

Knockdown of <Emphasis Type="Italic">MRP4</Emphasis> by lentivirus-mediated siRNA improves sensitivity to adriamycin in adriamycin-resistant acute myeloid leukemia cells

Chemotherapy remains the standard treatment for acute myeloid leukemia;however,the emergence of drug resistance is a major hurdle in the successful treatment of leukemia.The expression of multidrug resistance-associated protein 4(MRP4)induces re- sistance in the adriamycin-resistant acute myeloid leukemia cell line,K562/ADR.The aim of this study was to investigate whether knockdown of MRP4 by lentivirus-mediated siRNA could improve the sensitivity of K562/ADR cells to adriamycin.Five lenti- virus-mediated short hairpin RNAs(lv-shRNAs-MRP4)were designed to trigger the gene silencing RNA interference(RNAi) pathway.The efficiency of lentivirus-mediated siRNA infection into K562/ADR cells was determined using fluorescence mi- croscopy to observe lentivirus-mediated GFP expression.MRP4 expression in infected K562/ADR cells was evaluated by real- time PCR and Western blot analysis.The MTS assay was used to measure cell viability and flow cytometry was used to measure apoptosis.The transfection efficiency of K562/ADR cells was over 80 percent.The gene silencing efficacy of lv-shRNA1-MRP4 was superior to the other constructs.Infection of K562/ADR cells with lv-shRNA1-MRP4 led to strong inhibition of MRP4 mRNA and protein expression.Combined treatment with lv-shRNA1-MRP4 and adriamycin decreased cell growth and increased apoptosis compared to treatment with lv-shRNA1-MRP4 or adriamycin alone.These data indicate that in K562/ADR cells MRP4 is involved in drug resistance mechanisms and that lentivirus-mediated knockdown of MRP4 may enhance sensitivity to adriamycin.     

Homoharringtonine induces apoptosis of endothelium and down－regulates VEGF expression of K562 cells

Homoharringtonine (HHT) has currently been used successfully in the treatment of acute and chronic myeloid leukemias and has been shown to induce apoptosis of different types of leukemic cells in vitro. Emerging evidence suggests that angiogenesis may play an important role in hematological malignancies, such as leukemia. However, whether HHT can relieve leukemia by anti-angiogenesis is still unknown. We investigated the anti-angiogenesis potential of HHT with the human umbilical vein endothelial cell line (ECV304) and leukemic cell line (K562) in vitro. Cellular proliferation was determined by MTT assay and apoptosis was analyzed by flow cytometry, The mRNA expression of vascular endothelial growth factor (VEGF) was assessed by RT-PCR and VEGF protein production was detected by Western blot. Inhibition of cell proliferation and induction of apoptosis by HHT were discovered in ECV304 cells, and appeared in a dose- and time-dependent manner, Also, treatment with HHT caused down-regulation of VEGF mRNA expression in K562 cells in similar dose- and time-dependent manner and inhibition of VEGF protein production in K562 cells in response to the enhancing concentration of HHT. The results demonstrated that HHT could also induce apoptosis in endothelium and down-regulate VEGF expression in K562 cells. In conclusion, we believe HHT has anti-angiogenesis potential and speculate that HHT might exert its anti-leukemia effects via reduction of angiogenesis.     

柴胡皂甙d(SSd)对K562细胞增殖的抑制作用

目的研究从柴胡中提取的单体成分柴胡皂甙d对K562细胞生长的影响.方法分别用不同质量浓度的SSd作用于K562细胞株,于不同时间段分别计数其平均细胞数,并绘制相应生长曲线,计算平均抑制率.药物作用后24,36,48 h,计算分裂指数.结果用药后K562细胞的细胞数、分裂指数均下降,下降幅度与剂量呈正相关.结论 SSd能抑制K562细胞增殖,这种抑制作用呈时间和剂量依赖关系(P<0.05).     

灵芪胶囊含药血清对K562白血病细胞影响

观察灵芪胶囊含药血清在体外对K562白血病细胞增殖的影响.采用血清药理学方法制备灵芪胶囊含药血清,以不同浓度的含药血清处理体外培养的K562白血病细胞,采用MTT比色法观察灵芪胶囊含药血清对K562细胞增殖的影响,采用Wright-Giemsa染色观察肿瘤细胞形态学变化.不同浓度灵芪胶囊含药血清对K562细胞增殖具有抑制作用,并呈剂量依赖关系.当含药血清作用96h后,其抑制作用开始减弱.高剂量LQC含药血清对K562细胞形态学有明显的影响.灵芪胶囊含药血清具有抑制K562白血病细胞增殖作用,其作用强度与时间-浓度呈正相关,其作用机理可能与其直接细胞毒作用有关.     

Sorafenib联合重组人可溶性TRAIL蛋白对K562细胞增殖抑制和凋亡诱导的研究

目的观察比较联合应用重组人可溶性TRAIL蛋白及Sorafenib于人慢性髓系白血病细胞株K562与单独应用时细胞增殖抑制及诱导凋亡的差异。方法通过CCK-8法检测两者对K562细胞的增殖抑制作用;Western-Blot分析TRAIL或与Sorafenib联用对K562细胞的凋亡诱导作用。结果 Sorafenib与TRAIL联合作用于K562细胞时,其细胞的增殖抑制率及凋亡率均显著高于二者单独应用。结论 Sorafenib与TRAIL对K562细胞的增殖抑制及凋亡诱导有增敏及协同作用。